Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups
- PMID: 22723809
- PMCID: PMC3377888
- DOI: 10.2174/1874312901206010054
Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups
Abstract
Objective: Given the difficulties regarding the interpretation of common laboratory test results in polymyositis (PM) and dermatomyositis (DM) in clinical practice, we assessed their range of abnormalities, differences among phenotypes and interrelationships in a large referral population.
Methods: We retrospectively assessed 20 commonly measured blood laboratory tests in 620 well-defined PM/DM patients at different stages of illness and treatment to determine the frequency, range of abnormalities and correlations among clinical, gender, racial and age phenotypes.
Results: Myositis patients at various stages of their disease showed frequent elevations of the serum activities of creatine kinase (51%), alanine aminotransferase (43%), aspartate aminotransferase (51%), lactate dehydrogenase (60%), aldolase (65%) and myoglobin levels (48%) as expected. Other frequent abnormalities, however, included elevated high white blood cell counts (36%), low lymphocyte counts (37%), low hematocrit levels (29%), low albumin levels (22%), high creatine kinase MB isoenzyme fractions (52%), high erythrocyte sedimentation rates (33%) and high IgM and IgG levels (16% and 18%, respectively). Many of these tests significantly differed among the clinical, gender, racial and age groups. Significant correlations were also found among a number of these laboratory tests, particularly in the serum activity levels of creatine kinase, the transaminases, lactate dehydrogenase and aldolase.
Conclusion: Laboratory test abnormalities are common in PM/DM. Knowledge of the range of these expected abnormalities in different myositis phenotypes, gender and age groups and their correlations should assist clinicians in better interpretation of these test results, allow for a clearer understanding what level of abnormality warrants further evaluation for liver or other diseases, and may avoid unnecessary laboratory or other testing.
Keywords: Myositis; laboratory testing.; phenotypes.
Figures
Similar articles
-
[Role of magnetic resonance imaging in the diagnosis of juvenile dermato-myositis and polymyositis in Chinese children].Zhonghua Er Ke Za Zhi. 2016 Oct 2;54(10):767-772. doi: 10.3760/cma.j.issn.0578-1310.2016.10.011. Zhonghua Er Ke Za Zhi. 2016. PMID: 27784480 Chinese.
-
Myalgia in Patients with Dermatomyositis and Polymyositis Is Attributable to Fasciitis Rather Than Myositis: A Retrospective Study of 32 Patients who Underwent Histopathological Examinations.J Rheumatol. 2017 Apr;44(4):482-487. doi: 10.3899/jrheum.160763. Epub 2017 Feb 1. J Rheumatol. 2017. PMID: 28148694
-
Serum C1q Concentration Positively Correlates with Erythrocyte Sedimentation Rate in Polymyositis/Dermatomyositis.Ann Clin Lab Sci. 2019 Mar;49(2):237-241. Ann Clin Lab Sci. 2019. PMID: 31028070
-
[Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].Presse Med. 2003 Oct 25;32(35):1656-67. Presse Med. 2003. PMID: 14631270 Review. French.
-
Polymyositis-dermatomyositis--a 25-year follow-up of 50 patients (analysis of clinical symptoms and signs and results of laboratory tests).Mater Med Pol. 1990 Jul-Sep;22(3):205-12. Mater Med Pol. 1990. PMID: 2132428 Review.
Cited by
-
Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis.Rheumatol Int. 2019 May;39(5):901-909. doi: 10.1007/s00296-019-04255-2. Epub 2019 Feb 21. Rheumatol Int. 2019. PMID: 30790016
-
Disease spectrum of myopathies with elevated aldolase and normal creatine kinase.Eur J Neurol. 2024 Feb;31(2):e16117. doi: 10.1111/ene.16117. Epub 2023 Nov 3. Eur J Neurol. 2024. PMID: 37922500 Free PMC article.
-
Clinical spectrum and outcomes of idiopathic inflammatory myopathies in South Africans.Front Med (Lausanne). 2023 Feb 13;10:1097824. doi: 10.3389/fmed.2023.1097824. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36860335 Free PMC article.
-
Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study.Open Access Rheumatol. 2023 May 16;15:81-92. doi: 10.2147/OARRR.S410165. eCollection 2023. Open Access Rheumatol. 2023. PMID: 37214354 Free PMC article.
-
Biomarkers in Inflammatory Myopathies-An Expanded Definition.Front Neurol. 2019 Jun 4;10:554. doi: 10.3389/fneur.2019.00554. eCollection 2019. Front Neurol. 2019. PMID: 31214105 Free PMC article. Review.
References
-
- Miller FW. Inflammatory Myopathies: Polymyositis, dermatomyositis, and related conditions. In: Koopman W, Moreland L, editors. Arthritis and Allied Conditions. Philadelphia: Williams and Wilkins; 2005. pp. 1593–620. A Textbook of Rheumatology.
-
- Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve. 2003;27(4):407–25. - PubMed
-
- Munsat TL, Baloh R, Pearson CM, Fowler WJ. Serum enzyme alterations in neuromuscular disorders. J Am Med Assoc. 1973; 226:1536–43. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous